Literature DB >> 2799746

Topical nasal anaesthesia for fibreoptic bronchoscopy: patients' preference for lignocaine gel.

A R Webb1, M A Woodhead, H R Dalton, J A Grigg, F J Millard.   

Abstract

Two techniques for anaesthetising the nose before fibreoptic bronchoscopy have been compared. Fourteen of 16 patients given lignocaine spray found it unpleasant, compared with three of 20 patients given lignocaine gel. The two forms of local anaesthetic were found to be equally effective. Lignocaine gel is therefore recommended for topical nasal anaesthesia before fibreoptic bronchoscopy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2799746      PMCID: PMC462006          DOI: 10.1136/thx.44.8.674

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  2 in total

Review 1.  Measurement of feelings using visual analogue scales.

Authors:  R C Aitken
Journal:  Proc R Soc Med       Date:  1969-10

2.  Sedation for fibreoptic bronchoscopy: comparison of alfentanil with papaveretum and diazepam.

Authors:  A R Webb; J F Doherty; M R Chester; A R Cummin; M A Woodhead; E M Nanson; S T Flack; F J Millard
Journal:  Respir Med       Date:  1989-05       Impact factor: 3.415

  2 in total
  4 in total

1.  British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Topical nasal anaesthesia for fibreoptic bronchoscopy.

Authors:  B R O'Driscoll; J R Webb
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

3.  Local anaesthesia for fibreoptic bronchoscopy: transcricoid injection or the "spray as you go" technique?

Authors:  A R Webb; S S Fernando; H R Dalton; J E Arrowsmith; M A Woodhead; A R Cummin
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

4.  Topical Nasal Anesthesia in Flexible Bronchoscopy--A Cross-Over Comparison between Two Devices.

Authors:  Thomas Fuehner; Jan Fuge; Meike Jungen; Anna Buck; Hendrik Suhling; Tobias Welte; Jens Gottlieb; Mark Greer
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.